Back to Search
Start Over
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
- Source :
- Blood Cancer Journal, Vol 13, Iss 1, Pp 1-5 (2023)
- Publication Year :
- 2023
- Publisher :
- Nature Publishing Group, 2023.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20445385
- Volume :
- 13
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Blood Cancer Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.f9819aaa5aff4a02970deed6557e6a42
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41408-023-00898-4